The Institute of Radiation Medicine (IRM) is part of the Department of Radiation Sciences (DRS) of the Helmholtz Zentrum München (HMGU).

Since the 1st of January 2019, the Institute for Radiation Protection (ISS) has been integrated into the Institute of Radiation Medicine (IRM). Thus, the existing spectrum of the two departments could be merged and added complementarily. The institute covers all aspects of modern radiation research and focuses on translational issues and clinical applications. One focus is clinically oriented research on technical and biological issues of radiotherapy. This includes research into preclinical radiation biology and molecular biology, imaging, and new technological developments in radiation technology, providing a solid basis to bridge the gap between preclinical knowledge, theoretical computations and clinical application.

The IRM is closely associated with the Department of Radiation Oncology and Radiotherapy at the Klinikum rechts der Isar (TU München) as well as the German Consortium for Translational Cancer Research (DKTK) at its partner location in Munich.
Innovation and translation - these are the motivators in the individual emphases:

•    Cellular and Molecular Radiobiology
•    Marker of the individual radiation response
•    Characteristics of tumor and normal tissue
•    New irradiation modalities
•    Radiation protection
•    Therapeutic application of radiation in therapy and diagnostics
•    Personalized dosimetry